Skip to main content

Published locations for First-in-class antipsychotic linked to lower cardiometabolic risk

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. First-in-class antipsychotic linked to lower cardiometabolic risk

User login

  • Reset your password
  • /content/first-class-antipsychotic-linked-lower-cardiometabolic-risk
  • /clinicalendocrinologynews/article/223359/schizophrenia-other-psychotic-disorders/first-class
  • /psychiatry/article/223359/schizophrenia-other-psychotic-disorders/first-class-antipsychotic-linked
  • /ecardiologynews/article/223359/schizophrenia-other-psychotic-disorders/first-class-antipsychotic
  • /cardiology/article/223359/schizophrenia-other-psychotic-disorders/first-class-antipsychotic-linked
  • /endocrinology/article/223359/schizophrenia-other-psychotic-disorders/first-class-antipsychotic
  • /type-2-diabetes-icymi/article/223359/schizophrenia-other-psychotic-disorders/first-class
  • /clinicalpsychiatrynews/article/223359/schizophrenia-other-psychotic-disorders/first-class